Mechanisms by which autophagy regulates memory capacity in ageing

Area of Science:

• Neuroscience
• Molecular Biology
• Gerontology

Background:

• Autophagy agonists show potential for slowing neurodegeneration.
• Spermidine, an autophagy agonist, is being studied for age-related memory decline.
• Mechanisms of autophagy agonists in memory and synaptic plasticity require further investigation.

Purpose of the Study:

• To investigate the therapeutic potential of autophagy agonists in a novel mouse model of mild cognitive impairment (MCI).
• To elucidate the role of spermidine and TAT-Beclin 1 in mitigating cognitive decline and amyloid pathology.

Main Methods:

• Development of a mouse model exhibiting MCI, characterized by memory impairment and amyloid accumulation.
• Treatment of MCI mice with subchronic doses of Spermidine and TAT-Beclin 1.
• Assessment of memory capacity, lysosomal amyloid degradation, and hippocampal GluA1 post-translational modifications.

Main Results:

• The novel MCI mouse model displayed impaired memory, lysosomal amyloid burden, and altered GluA1 modifications.
• Spermidine and TAT-Beclin 1 treatments significantly rescued memory capacity in MCI mice.
• Both treatments enhanced autophagy/lysosomal-mediated degradation of amyloid fibrils (β-amyloid and α-synuclein), restoring GluA1 modifications.

Conclusions:

• Autophagy enhancers, like Spermidine and TAT-Beclin 1, can reverse cognitive deficits in a mouse model of MCI.
• These agents function by promoting the degradation of misfolded amyloid proteins via the autophagy-lysosomal pathway.
• Targeting autophagy represents a promising therapeutic strategy for combating age-related memory decline and neurodegeneration.